Taysha Gene Therapies, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q4 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Taysha Gene Therapies, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q4 2019 to Q1 2024.
  • Taysha Gene Therapies, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $1.33M, a 18.1% increase year-over-year.
  • Taysha Gene Therapies, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $4.95M, a 78.5% increase from 2022.
  • Taysha Gene Therapies, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.78M, a 333% increase from 2021.
  • Taysha Gene Therapies, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $641K, a 2189% increase from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.33M +$204K +18.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $1.13M +$706K +168% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $419K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2019 $0 Sep 21, 2019 Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.